Last reviewed · How we verify

diphtheria, tetanus, pertussis & Hib vaccine

GlaxoSmithKline · Phase 3 active Biologic

diphtheria, tetanus, pertussis & Hib vaccine is a vaccine Biologic drug developed by GlaxoSmithKline. It is currently in Phase 3 development for Prevention of diphtheria, tetanus, pertussis, and Haemophilus influenzae type b infections in infants and children. Also known as: diphtheria, tetanus, pertussis & Hib vaccine.

This vaccine stimulates the body's immune response to produce antibodies against diphtheria, tetanus, pertussis, and Haemophilus influenzae type b.

This vaccine stimulates the body's immune response to produce antibodies against diphtheria, tetanus, pertussis, and Haemophilus influenzae type b. Used for Prevention of diphtheria, tetanus, pertussis, and Haemophilus influenzae type b infections in infants and children.

At a glance

Generic namediphtheria, tetanus, pertussis & Hib vaccine
Also known asdiphtheria, tetanus, pertussis & Hib vaccine
SponsorGlaxoSmithKline
Drug classvaccine
ModalityBiologic
Therapeutic areaImmunology
PhasePhase 3

Mechanism of action

The vaccine contains inactivated or attenuated pathogens, which are introduced to the body to trigger an immune response. This response produces antibodies that can recognize and neutralize the pathogens, providing immunity against future infections.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about diphtheria, tetanus, pertussis & Hib vaccine

What is diphtheria, tetanus, pertussis & Hib vaccine?

diphtheria, tetanus, pertussis & Hib vaccine is a vaccine drug developed by GlaxoSmithKline, indicated for Prevention of diphtheria, tetanus, pertussis, and Haemophilus influenzae type b infections in infants and children.

How does diphtheria, tetanus, pertussis & Hib vaccine work?

This vaccine stimulates the body's immune response to produce antibodies against diphtheria, tetanus, pertussis, and Haemophilus influenzae type b.

What is diphtheria, tetanus, pertussis & Hib vaccine used for?

diphtheria, tetanus, pertussis & Hib vaccine is indicated for Prevention of diphtheria, tetanus, pertussis, and Haemophilus influenzae type b infections in infants and children.

Who makes diphtheria, tetanus, pertussis & Hib vaccine?

diphtheria, tetanus, pertussis & Hib vaccine is developed by GlaxoSmithKline (see full GlaxoSmithKline pipeline at /company/gsk).

Is diphtheria, tetanus, pertussis & Hib vaccine also known as anything else?

diphtheria, tetanus, pertussis & Hib vaccine is also known as diphtheria, tetanus, pertussis & Hib vaccine.

What drug class is diphtheria, tetanus, pertussis & Hib vaccine in?

diphtheria, tetanus, pertussis & Hib vaccine belongs to the vaccine class. See all vaccine drugs at /class/vaccine.

What development phase is diphtheria, tetanus, pertussis & Hib vaccine in?

diphtheria, tetanus, pertussis & Hib vaccine is in Phase 3.

What are the side effects of diphtheria, tetanus, pertussis & Hib vaccine?

Common side effects of diphtheria, tetanus, pertussis & Hib vaccine include Injection site pain, Fever, Irritability.

Related